Tumefactive and longitudinally extensive myelitis: A rare presentation of multiple sclerosis?

Cerebral tumefactive demyelinating lesions are well described in multiple sclerosis (MS). Yet few cases of MS-associated tumefactive spinal cord demyelination have been described. We report a patient with a clinical course typical of relapsing-remitting MS who presented with a relapse associated with a tumefactive and longitudinally extensive cervical spinal cord lesion. Despite extensive evaluation, and with two years of longitudinal follow up, no better explanation than MS could be identified. This case highlights the diagnostic and prognostic challenges associated with presumed tumefactive spinal cord demyelination in MS, and the unmet need for further cases to guide therapeutic decision-making.

Authors

Institutions

Publication Details

Journal
Neuroimmunology Reports
Published
2025-01-01
DOI
https://doi.org/10.1016/j.nerep.2025.100257
Citations
1
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tumefactive and longitudinally extensive myelitis: A rare presentation of multiple sclerosis?

Andrew J Solomon, Eoin P. Flanagan, Adam L. Morehead
1 citations
Neuroimmunology Reports
Multiple Sclerosis Research Studies
1.47
article

Tumefactive and longitudinally extensive myelitis: A rare presentation of multiple sclerosis?

Andrew J Solomon, Eoin P. Flanagan, Adam L. Morehead
article en
1 citations

Abstract

Cerebral tumefactive demyelinating lesions are well described in multiple sclerosis (MS). Yet few cases of MS-associated tumefactive spinal cord demyelination have been described. We report a patient with a clinical course typical of relapsing-remitting MS who presented with a relapse associated with a tumefactive and longitudinally extensive cervical spinal cord lesion. Despite extensive evaluation, and with two years of longitudinal follow up, no better explanation than MS could be identified. This case highlights the diagnostic and prognostic challenges associated with presumed tumefactive spinal cord demyelination in MS, and the unmet need for further cases to guide therapeutic decision-making.

Neuroimmunology ReportsVol. 7
University of Vermont (US), Mayo Clinic (US)
Good health and well-being
Openalex Percentile: Top 21%
Multiple Sclerosis Research Studies
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.